Mrs. Adeola Obajemu, a Nigerian-born American citizen is the Founder of RiseRenewed, a community outreach and intervention group that provides support to the vulnerable family and children in the United States and Africa.  

Mrs. Obajemu served on the staff of the National Institutes of Health (NIH), a world-renowned medical research center and America’s primary federal biomedical research agency. During her tenure at NIH, she played a pivotal role in advancing the organization’s mission to improve national health through groundbreaking discovery and innovation, disease prevention, and the expansion of biomedical knowledge. 

Mrs. Obajemu’s advocacy extends beyond traditional medical research, as she has a keen interest in policies aimed at achieving universal health coverage and sustainable development. While at NIH, she actively mentored young researchers, contributing to the development of the next generation of scientific leaders. 

She has received citation in many publications for her research papers, including: Donor IFNL4 genotype predicts non-relapse mortality after unrelated donor myeloablative hematopoietic cell transplantation for acute leukemia: A retrospective cohort study. 

Recognized for her significant contributions to the exploration of genetic risk factors for bladder cancer, Mrs. Obajemu was honored with the prestigious Kelly Government Distinguished Achievement Award in 2020. This accolade highlights her efforts in improving the economy, efficiency, and effectiveness of NIH programs and missions. 

In addition to her research accomplishments, Mrs. Obajemu served as an officer of the Food and Drug Administration (FDA), further expanding her impact on public health policies. Her multifaceted expertise uniquely positions her to navigate the complex intersection of research, policy, and public health. 

Beyond her professional achievements, Mrs. Obajemu is the esteemed host of the RiseRenewed Talk Show, where she continues to amplify important conversations on health, well-being, and social issues. Her leadership and advocacy make her an invaluable asset to the nonprofit sector, embodying a commitment to positive change and community empowerment. 

She was on the staff of the National Institutes of Health (NIH), one of the world’s foremost medical research centers and America’s primary federal biomedical research agency set up to improve national health through discovery and innovation, prevention of disease, expansion of the biomedical knowledge base, and promotion of high-level scientific conduct. 

Mrs. Obajemu brings a wealth of experience and dedication to her role as a member of the board. She has demonstrated a passionate commitment to addressing critical social issues.  

Her interest in policies aimed at universal health coverage and sustainable development. She provided mentorship to young researchers, while at NIH. For her significant contribution to the research on exploration of genetic risk factors for bladder cancer, and support that improves the economy, efficiency, and effectiveness of NIH program and mission, she received the Kelly Government Distinguished Achievement Awards in the 2020.  

She has received citation in many publications for her research papers, including: Donor IFNL4 genotype predicts non-relapse mortality after unrelated donor myeloablative hematopoietic cell transplantation for acute leukemia: A retrospective cohort study. 

Most recently, she served as an officer of the Food and Drug Administration (FDA). 

She’s the host RiseRenewed Talk Show